Anticoagulación en pacientes con fibrilación auricular. ¿Qué dicen las recomendaciones de las guías de práctica clínica? / Anticoagulation in patients with atrial fibrillation. What do clinical practice recommendations guidelines say?
Rev. costarric. cardiol
;
19(1/2): 5-8, ene.-dic. 2017. graf
Article
in Spanish
| LILACS
| ID: biblio-900879
RESUMEN
Resumen La fibrilación auricular es una de las cardiopatías con mayor prevalencia. Para escoger la terapia ideal se debe evaluar el riesgo hemorrágico con la escala de HASBLED y el riesgo de sufrir un evento cerebrovascular con la escala del CHADS VASC. Se recomienda utilizar el algoritmo de las guías ESC 2016 para prevención de un ictus por fibrilación auricular, donde los NOAC deben preferirse a los antagonistas de la vitamina K
ABSTRACT
Abstract Anticoagulation in patients with atrial fibrillation. What do clinical practice recommendations guidelines say? Atrial fibrillation is one of the most prevalent heart disease. In order to choose the ideal therapy, the risk of hemorrhagic risk should be evaluated with the HASBLED score and the risk of suffering a cerebrovascular event with the CHADSVASC score. It is recommended to use the algorithm of ESC 2016 guidelines for the prevention of stroke in atrial fibrillation, where NOAC should be preferred to vitamin K antagonists.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Atrial Fibrillation
/
Warfarin
/
Practice Guideline
/
Heart Diseases
/
Heart Failure
/
Anticoagulants
Type of study:
Practice guideline
/
Risk factors
Limits:
Humans
Language:
Spanish
Journal:
Rev. costarric. cardiol
Journal subject:
Cardiology
Year:
2017
Type:
Article
Affiliation country:
Spain
Institution/Affiliation country:
Universidad de Santiago Compostela/ES
Similar
MEDLINE
...
LILACS
LIS